Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q4 FY23 results · Jan–Mar 2023
Unichem Laboratories reported revenue from operations of ₹402.10 crore (up 8.7% from Q4 FY22) and net loss of ₹44.27 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 402.10 | 369.95 | +8.7% | 302.50 | +32.9% |
| Other income | 5.11 | 14.39 | −64.5% | 16.35 | −68.7% |
| Total income | 407.21 | 384.34 | +5.9% | 318.85 | +27.7% |
| Profit before tax | (47.16) | 57.94 | Turned loss | (61.28) | Loss narrowed |
| Net profit for the period | (44.27) | 71.47 | Turned loss | (63.93) | Loss narrowed |
| EPS, basic (₹) | (6.28) | 10.15 | Turned loss | (9.08) | Loss narrowed |
| Net margin (%) | -11.0 | 19.3 | -21.1 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 310.06 | 276.86 | +12.0% | 251.95 | +23.1% |
| Other income | 3.79 | 9.08 | −58.3% | 15.43 | −75.5% |
| Total income | 313.85 | 285.94 | +9.8% | 267.38 | +17.4% |
| Profit before tax | (143.83) | (0.28) | Loss widened | (57.12) | Loss widened |
| Net profit for the period | (143.83) | 17.33 | Turned loss | (57.12) | Loss widened |
| EPS, basic (₹) | (20.43) | 2.46 | Turned loss | (8.11) | Loss widened |
| Net margin (%) | -46.4 | 6.3 | -22.7 |
Consolidated
- Filed with BSE
- 23 May 2023, 14:56 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2023, 14:56 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE